Emerging Markets Look to 2021 as Goldman Adds to Bullish Calls
- Outlook hinges on ‘virus-versus-vaccine trajectory’: Fidelity
- South Korea, Nigeria, Colombia seen holding interest rates
This article is for subscribers only.
It may come down to another pharmaceutical breakthrough to set the tone for emerging markets headed toward 2021.
Developing-nation stocks, currencies and bonds rose for a third week in the five days through Friday, and maintained their resilience on Monday, as the prospect of a coronavirus vaccine roll-out in the months ahead outweighed concern that rising infections would lead to tougher curbs in the nearer term. Underscoring investor optimism, a measure of implied volatility for currencies is near the lowest in almost four months.